Randomized Control Trial: Elbow Extension Versus Flexion Cast in Proximal Half Both Bone Forearm Fractures

NCT ID: NCT05470257

Last Updated: 2024-06-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

75 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-07

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare outcomes between two immobilization methods for pediatric proximal half both bone forearm fractures.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After being informed of the study including potential risks and benefits, all patients giving assent and guardian/parents consent who meet eligibility will undergo randomization of the casting technique used (elbow extension or elbow flexion casting). Randomization will occur using a random umber generator. Even numbers generated will result in an extension cast and odd numbers generated will result in a flexion cast.

The patients will be followed in clinic with an examination and x-rays at 2, 3, 5, and 8 weeks after casting to evaluate alignment of the fracture maintained by each cast. The two cohorts will be compared at the end of the study to determine which casting technique is the superior immobilization for pediatric proximal half both bone forearm fractures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fracture of Radius and Ulna

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Two cohorts will be established. One will include patients casted in elbow extension. The other cohort will include patients casted in elbow flexion.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Casting is an external treatment that cannot be masked from investigators or participants.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Elbow Flexion Cast

This cohort will be placed in a long arm flexion cast.

Group Type EXPERIMENTAL

Cast

Intervention Type OTHER

Application of fiberglass long arm cast.

Elbow Extension Cast

This cohort will be placed in a long arm extension cast.

Group Type EXPERIMENTAL

Cast

Intervention Type OTHER

Application of fiberglass long arm cast.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cast

Application of fiberglass long arm cast.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ages 3-18
* Skeletally immature
* Unilateral Radius and Ulna Fracture located within the proximal ½ of each bone
* Fracture requires reduction and casting

Exclusion Criteria

* Ages \< 3
* Distal ½ Radius and Ulna Forearm Fracture
* Isolated radius or ulna fracture
* Humerus Fracture of the Ipsilateral Arm (including floating elbow)
* Metabolic Bone Disease
* Open Fractures
* Monteggia and Galeazzi Fractures
* Deformity or abnormality not allowing for standard casting (limb deficiency, contracture)
* Parent speaks language other than english
Minimum Eligible Age

3 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institutes of Health (NIH)

NIH

Sponsor Role collaborator

University of Alabama at Birmingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Philip Ashley

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Children's of Alabama

Birmingham, Alabama, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

T35HL007473

Identifier Type: NIH

Identifier Source: secondary_id

View Link

BBFARCT

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Long-Arm vs Sugar-Tong
NCT03724773 WITHDRAWN NA